SUBSCribe
logo
twitterlinkedininstagramUser Profile
search
  • BIG STORY
  • PERSPECTIVE
    • Editor's Note
  • ENTERPRISE
    • STRATEGY
      • HIGH FIVE
      • AD Break
    • MARKETS
      • PIXTORY
        • SPECIALS
        • VIDEOS
        • Spotlight Initiatives
        • C’est La Vie
          • My Favourite
          • Pursuit of Happiness
          • The Good Life
          • Hardbound
        • MAGAZINE
        • EVENTS
          • LEADING EDGE
          • SMART ENTERPRISE
        • Plain relief or pain relief?

          Omnigel India’s latest ad nudges consumers towards choosing a lasting solution for body aches, over momentary relief

          Yashasvini Razdan - February 12, 2021
        • What does Rakesh Jhunjhunwala see in Jubilant Life Sciences?

          Within a year, the investing legend has doubled down on his latest pharma bet

          Himanshu Kakkar - May 23, 2020
        • Cipla’s American Odyssey

          The pharma major has made a few tough decisions over the past few years. Now, it’s beginning to pay off

          Kripa Mahalingam - January 22, 2020
        • Seeking a Safe Haven

          As the market tumbles, mutual fund managers recommend pharma, private banks and specialty chemicals to tide over the volatility

          Prathamesh Mulye - January 08, 2019
        • Uphill Climb

          The pharma industry has to deal with poor road connectivity and an unskilled labour force in Sikkim, but it seems to have made peace with the mountains

          Himanshu Kakkar - January 25, 2019
        • Inflection point

          Laurus Labs is crucially poised, as investors look forward to its R&D efforts finally paying off

          Khushboo Balani - April 04, 2018
        • Opportunistic Buyer

          Sailesh Raj Bhan has made optimum use of cyclical downturns to deliver outperformance

          Khushboo Balani - January 25, 2018
        • Nursing Back to Health

          A strong product pipeline and receding US FDA threat could well turn the tide in favour of the beleaguered pharma players

          Jash Kriplani - October 18, 2017
        • Ajay Relan

          His bet on Natco Pharma’s differentiated product portfolio paid off while Monnet Ispat taught him to be wary of over-ambitious entrepreneurs

          Krishna Gopalan - September 18, 2017
        • Kick The Butt

          To quit smoking isn't easy but it's possible, Nicotex shows you how

          Somdyuti Datta Ray - September 20, 2017